[HTML][HTML] SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
…, G Regev-Yochay, Y Lustig, RD Balicer - Nature Reviews …, 2022 - nature.com
Breakthrough infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
in fully vaccinated individuals are receiving intense scrutiny because of their importance in …
in fully vaccinated individuals are receiving intense scrutiny because of their importance in …
[HTML][HTML] BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting
…, M Lipsitch, B Reis, RD Balicer - … England Journal of …, 2021 - Mass Medical Soc
Background As mass vaccination campaigns against coronavirus disease 2019 (Covid-19)
commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes …
commence worldwide, vaccine effectiveness needs to be assessed for a range of outcomes …
[HTML][HTML] Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study
Background Many countries are experiencing a resurgence of COVID-19, driven predominantly
by the delta (B.1.617.2) variant of SARS-CoV-2. In response, these countries are …
by the delta (B.1.617.2) variant of SARS-CoV-2. In response, these countries are …
[HTML][HTML] Myocarditis after Covid-19 vaccination in a large health care organization
…, O Auster, N Dagan, RD Balicer… - … England Journal of …, 2021 - Mass Medical Soc
Background Reports have suggested an association between the development of myocarditis
and the receipt of messenger RNA (mRNA) vaccines against coronavirus disease 2019 (…
and the receipt of messenger RNA (mRNA) vaccines against coronavirus disease 2019 (…
[HTML][HTML] Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals
The BNT162b2 mRNA vaccine is highly effective against SARS-CoV-2. However, apprehension
exists that variants of concern (VOCs) may evade vaccine protection, due to evidence of …
exists that variants of concern (VOCs) may evade vaccine protection, due to evidence of …
[HTML][HTML] Safety of the BNT162b2 mRNA Covid-19 vaccine in a nationwide setting
Background Preapproval trials showed that messenger RNA (mRNA)–based vaccines against
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a good safety profile…
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a good safety profile…
[HTML][HTML] Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy
…, M Lipsitch, S Hernandez-Diaz, BY Reis, RD Balicer - Nature medicine, 2021 - nature.com
To evaluate the effectiveness of the BNT162b2 messenger RNA vaccine in pregnant women,
we conducted an observational cohort study of pregnant women aged 16 years or older, …
we conducted an observational cohort study of pregnant women aged 16 years or older, …
Prediction of acute myeloid leukaemia risk in healthy individuals
The incidence of acute myeloid leukaemia (AML) increases with age and mortality exceeds
90% when diagnosed after age 65. Most cases arise without any detectable early symptoms …
90% when diagnosed after age 65. Most cases arise without any detectable early symptoms …
[HTML][HTML] SARS-CoV-2 variants and vaccines
…, H Rees, AM Ropero, RD Balicer… - … England Journal of …, 2021 - Mass Medical Soc
Viral variants of concern may emerge with dangerous resistance to the immunity generated
by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some …
by the current vaccines to prevent coronavirus disease 2019 (Covid-19). Moreover, if some …
Functional status before and during acute hospitalization and readmission risk identification
BACKGROUND Recent efforts to prevent readmissions are increasingly focusing on early
identification of high‐risk patients. OBJECTIVE To test whether information on functioning …
identification of high‐risk patients. OBJECTIVE To test whether information on functioning …